| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |







From the Digestive Diseases Research Center,*St. Bartholomews and The Royal London School of Medicine and Dentistry, London; the Department of Pathology and Microbiology,
Division of Histopathology, Bristol Royal Infirmary, University of Bristol, Bristol; the Medical Research Council Laboratory for Molecular Cell Biology
and Department of Biochemistry and Molecular Biology, University College London, London; and the Division of Diagnostic and Investigative Science,
Imperial College School of Medicine, Hammersmith Hospital, London, United Kingdom
In epithelial tissue, cell-matrix and cell-cell adhesive interactions have important roles in the normal organization and stabilization of the cell layer. The malignant conversion of epithelial cells involves alterations in the expression and function of these adhesion systems that enable a switch to a migratory phenotype in tumor invasion and metastasis. Fascin is an actin-crosslinking protein that is found in the core actin bundles of cell-surface spikes and projections that are implicated in cell motility. We demonstrate that fascin is not detectable in normal colonic epithelium, but is dramatically up-regulated in colorectal adenocarcinoma. To test the hypothesis that fascin could participate in tumor invasive behavior, we developed a cell culture model to examine the effect of fascin expression on the adhesive interactions, invasiveness, and differentiation of colonic epithelial cells. We report marked effects on the organization of cell-surface protrusions, actin cytoskeleton, and focal adhesions in the absence of alterations in the protein levels of the major components of these structures. These effects correlate with alterations in cell movements on two-dimensional matrix, and increased invasiveness in three-dimensional matrix. The cells also show increased proliferation and decreased capacity for normal glandular differentiation in collagen gels. We propose that up-regulation of fascin, by promoting the formation of protrusive, actin-based, cell-motility structures, could be a significant component in the acquisition of invasive phenotype in colonic carcinoma.
This article has been cited by other articles:
![]() |
J.-J. Xie, L.-Y. Xu, J.-Y. Wu, Z.-Y. Shen, Q. Zhao, Z.-P. Du, Z. Lv, W. Gu, F. Pan, X.-E Xu, et al. Involvement of CYR61 and CTGF in the Fascin-Mediated Proliferation and Invasiveness of Esophageal Squamous Cell Carcinomas Cells Am. J. Pathol., February 1, 2010; 176(2): 939 - 951. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wu, L. Chen, W. Liao, Y. Ding, Q. Zhang, Z. Li, and L. Liu Fascin1 expression predicts poor prognosis in patients with nasopharyngeal carcinoma and correlates with tumor invasion Ann. Onc., September 16, 2009; (2009) mdp333v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fu, Z. Hu, J. Wen, K. Wang, and Y. Liu TGF-{beta} promotes invasion and metastasis of gastric cancer cells by increasing fascin1 expression via ERK and JNK signal pathways Acta Biochim Biophys Sin, August 1, 2009; 41(8): 648 - 656. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Darnel, E. Behmoaram, R. T. Vollmer, J. Corcos, K. Bijian, K. Sircar, J. Su, J. Jiao, M. A. Alaoui-Jamali, and T. A. Bismar Fascin Regulates Prostate Cancer Cell Invasion and Is Associated with Metastasis and Biochemical Failure in Prostate Cancer Clin. Cancer Res., February 15, 2009; 15(4): 1376 - 1383. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-R. Zhang, L.-H. Tao, Z.-Y. Shen, Z. Lv, L.-Y. Xu, and E.-M. Li Fascin Expression in Human Embryonic, Fetal, and Normal Adult Tissue J. Histochem. Cytochem., February 1, 2008; 56(2): 193 - 199. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hashimoto, M. Parsons, and J. C. Adams Dual Actin-bundling and Protein Kinase C-binding Activities of Fascin Regulate Carcinoma Cell Migration Downstream of Rac and Contribute to Metastasis Mol. Biol. Cell, November 1, 2007; 18(11): 4591 - 4602. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-C. Tsai, J.-S. Jin, W.-K. Chang, D.-C. Chan, M.-K. Yeh, S.-C. Cherng, L.-F. Lin, L.-F. Sheu, and Y.-C. Chao Association of Cortactin and Fascin-1 Expression in Gastric Adenocarcinoma: Correlation With Clinicopathological Parameters J. Histochem. Cytochem., September 1, 2007; 55(9): 955 - 962. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Vignjevic, M. Schoumacher, N. Gavert, K.-P. Janssen, G. Jih, M. Lae, D. Louvard, A. Ben-Ze'ev, and S. Robine Fascin, a Novel Target of {beta}-Catenin-TCF Signaling, Is Expressed at the Invasive Front of Human Colon Cancer Cancer Res., July 15, 2007; 67(14): 6844 - 6853. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Choi, D. K. Yang, C. H. Son, K. E. Lee, J. I. Lee, and M. S. Roh Fascin immunoreactivity for preoperatively predicting lymph node metastases in peripheral adenocarcinoma of the lung 3cm or less in diameter. Eur. J. Cardiothorac. Surg., September 1, 2006; 30(3): 538 - 542. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Zhang, L Xu, D Xiao, J Xie, H Zeng, W Cai, Y Niu, Z Yang, Z Shen, and E Li Fascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma J. Clin. Pathol., September 1, 2006; 59(9): 958 - 964. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Link, L. Carvalho, I. Castanon, P. Stockinger, A. Shevchenko, and C.-P. Heisenberg Identification of regulators of germ layer morphogenesis using proteomics in zebrafish J. Cell Sci., May 15, 2006; 119(10): 2073 - 2083. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hashimoto, T. Ito, H. Inoue, T. Okumura, E. Tanaka, S. Tsunoda, M. Higashiyama, G. Watanabe, M. Imamura, and Y. Shimada Prognostic Significance of Fascin Overexpression in Human Esophageal Squamous Cell Carcinoma Clin. Cancer Res., April 1, 2005; 11(7): 2597 - 2605. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Yoder, E. Tso, M. Skacel, J. Pettay, S. Tarr, T. Budd, R. R. Tubbs, J. C. Adams, and D. G. Hicks The Expression of Fascin, an Actin-Bundling Motility Protein, Correlates with Hormone Receptor-Negative Breast Cancer and a More Aggressive Clinical Course Clin. Cancer Res., January 1, 2005; 11(1): 186 - 192. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |